Literature DB >> 11963825

Cerebral endothelial cells are a major source of adrenomedullin.

B Kis1, H Kaiya, R Nishi, M A Deli, C S Abrahám, T Yanagita, T Isse, S Gotoh, H Kobayashi, A Wada, M Niwa, K Kangawa, J Greenwood, H Yamashita, Y Ueta.   

Abstract

Adrenomedullin is a peptide hormone with multifunctional biological properties. Its most characteristic effects are the regulation of circulation and the control of fluid and electrolyte homeostasis through peripheral and central nervous system actions. Although adrenomedullin is a vasodilator of cerebral vasculature, and it may be implicated in the pathomechanism of cerebrovascular diseases, the source of adrenomedullin in the cerebral circulation has not been investigated thus far. We measured the secretion of adrenomedullin by radioimmunoassay and detected adrenomedullin mRNA expression by Northern blot analysis in primary cultures of rat cerebral endothelial cells (RCECs), pericytes and astrocytes. We also investigated the expression of specific adrenomedullin receptor components by reverse transcriptase-polymerase chain reaction and intracellular cAMP concentrations in RCECs and pericytes. RCECs had approximately one magnitude higher adrenomedullin production (135 +/- 13 fmol/10(5) cells per 12 h; mean +/- SD, n = 10) compared to that previously reported for other cell types. RCECs secreted adrenomedullin mostly at their luminal cell membrane. Adrenomedullin production was not increased by thrombin, lipopolysaccharide or cytokines, which are known inducers of adrenomedullin release in peripheral endothelial cells, although it was stimulated by astrocyte-derived factors. Pericytes had moderate, while astrocytes had very low basal adrenomedullin secretion. In vivo experiments showed that adrenomedullin plasma concentration in the jugular vein of rats was approximately 50% higher than that in the carotid artery or in the vena cava. Both RCECs and pericytes, which are potential targets of adrenomedullin in cerebral microcirculation, expressed adrenomedullin receptor components, and exhibited a dose-dependent increase in intracellular cAMP concentrations after exogenous adrenomedullin administration. Antisense oligonucleotide treatment significantly reduced adrenomedullin production by RCECs and tended to decrease intraendothelial cAMP concentrations. These findings may suggest an important autocrine and paracrine role for adrenomedullin in the regulation of cerebral circulation and blood-brain barrier functions. Cerebral endothelial cells are a potential source of adrenomedullin in the central nervous system, where adrenomedullin can also be involved in the regulation of neuroendocrine functions.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11963825     DOI: 10.1046/j.1365-2826.2002.00778.x

Source DB:  PubMed          Journal:  J Neuroendocrinol        ISSN: 0953-8194            Impact factor:   3.627


  17 in total

Review 1.  Brain meets body: the blood-brain barrier as an endocrine interface.

Authors:  William A Banks
Journal:  Endocrinology       Date:  2012-07-09       Impact factor: 4.736

Review 2.  From blood-brain barrier to blood-brain interface: new opportunities for CNS drug delivery.

Authors:  William A Banks
Journal:  Nat Rev Drug Discov       Date:  2016-01-22       Impact factor: 84.694

3.  Adrenomedullin improves the blood-brain barrier function through the expression of claudin-5.

Authors:  Masaru Honda; Shinsuke Nakagawa; Kentaro Hayashi; Naoki Kitagawa; Keisuke Tsutsumi; Izumi Nagata; Masami Niwa
Journal:  Cell Mol Neurobiol       Date:  2006-04-20       Impact factor: 5.046

Review 4.  The blood-brain barrier: connecting the gut and the brain.

Authors:  William A Banks
Journal:  Regul Pept       Date:  2008-04-07

5.  The neuronal oxygen-sensing pathway controls postnatal vascularization of the murine brain.

Authors:  Emil Nasyrov; Karen A Nolan; Roland H Wenger; Hugo H Marti; Reiner Kunze
Journal:  FASEB J       Date:  2019-08-30       Impact factor: 5.191

6.  Iptakalim, an ATP-sensitive potassium channel opener, confers neuroprotection against cerebral ischemia/reperfusion injury in rats by protecting neurovascular unit cells.

Authors:  Yu-hua Ran; Hai Wang
Journal:  J Zhejiang Univ Sci B       Date:  2011-10       Impact factor: 3.066

7.  Cerebromicrovascular endothelial cells are resistant to L-glutamate.

Authors:  Ferenc Domoki; Béla Kis; Tamás Gáspár; Ferenc Bari; David W Busija
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2008-07-30       Impact factor: 3.619

8.  Pharmacological inhibition of mitochondrial carbonic anhydrases protects mouse cerebral pericytes from high glucose-induced oxidative stress and apoptosis.

Authors:  Gul N Shah; Tulin O Price; William A Banks; Yoichi Morofuji; Andrej Kovac; Nuran Ercal; Christine M Sorenson; Eui S Shin; Nader Sheibani
Journal:  J Pharmacol Exp Ther       Date:  2012-12-17       Impact factor: 4.030

9.  Involvement of calcitonin gene-related peptide and receptor component protein in experimental autoimmune encephalomyelitis.

Authors:  Claudia Sardi; Laura Zambusi; Annamaria Finardi; Francesca Ruffini; Adviye A Tolun; Ian M Dickerson; Marco Righi; Daniele Zacchetti; Fabio Grohovaz; Luciano Provini; Roberto Furlan; Stefano Morara
Journal:  J Neuroimmunol       Date:  2014-03-19       Impact factor: 3.478

Review 10.  Intermedin (adrenomedullin-2): a novel counter-regulatory peptide in the cardiovascular and renal systems.

Authors:  D Bell; B J McDermott
Journal:  Br J Pharmacol       Date:  2007-10-29       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.